Ventilator-associated pneumonia in adults: a narrative review | SpringerLink
Update on ventilator-associated pneumonia | F1000Research
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE
Ventilator-associated pneumonia: A review of the clinically relevant challenges in diagnosis and prevention | British Journal of Medical Practitioners
Phase 3 Study for Ventilator-Associated Pneumonia (VAP)
How I diagnose and manage ventilator-associated tracheobronchitis | Medicina Intensiva
Molecular Profiling of Innate Immune Response Mechanisms in Ventilator-associated Pneumonia - Molecular & Cellular Proteomics
American Thoracic Society Documents
The Prevention of Ventilator-Associated Pneumonia | NEJM
Levofloxacin in the treatment of ventilator-associated pneumonia - Clinical Microbiology and Infection
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation - The Lancet Respiratory Medicine
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE
Diagnosis and Treatment of Ventilator-Associated Pneumonia - CHEST
Short- vs Long-Duration Antibiotic Regimens for Ventilator-Associated Pneumonia - CHEST
Ventilator-associated pneumonia: The central role of transcolonization - ScienceDirect
Empiric treatment VAP (adults) - UpToDate
Management of Ventilator-Associated Pneumonia - Clinics in Chest Medicine
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial - The Lancet Infectious Diseases
Missouri Society of Health-System Pharmacists - Diagnosis and Treatment of Adults with Community-acquired Pneumonia: 2019 Clinical Practice Guidelines
JCM | Free Full-Text | Ventilator-Associated Pneumonia and PaO2/FIO2 Diagnostic Accuracy: Changing the Paradigm?
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia | European Respiratory Society
Ventilator Associated Pneumonia (VAP) - EMCrit Project
Updated IDSA/ATS Guidelines on Management of Adults With HAP and VAP
Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa | Scientific Reports
Strategies to reduce non-ventilator-associated hospital-acquired pneumonia: A systematic review - Infection, Disease & Health
Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study | Annals of Intensive Care | Full Text
